Hofseth BioCare will announce its results for the second quarter and first half year 2012 on 22 August. The results will be available from 0800 am CET at the company's homepage, www.hofsethbiocare.no and www.newsweb.no, as well as through news agencies.
Management, represented by CEO Sjur Jenssen and CFO Magne Aarsnes, will present the company and its results at 1100 am CET at the premises of SEB Enskilda, Filipstad Brygge 1 at Aker Brygge in Oslo.
Registration for the presentation must be submitted to Magne Aarsnes at ma@h-bc.no by Monday 21 August.
For more information, please contact:
Magne Aarsnes, CFO, tel: +47 900 12 212
About Hofseth BioCare:
Hofseth BioCare is a Norwegian biomarine company with the key objective to provide high value added biomarine ingredients for human applications. The Company is founded on the core value of sustainability and optimal use of natural resources. Through innovative production technology and logistics, Hofseth BioCare is able to preserve the quality of protein, calcium and oil extracted from fish off-cuts. Products that previously could only be used as animal feed can now be made suitable for human consumption. HBCs objective is thus to contribute to efficient use of marine resources and entering the higher profit market of quality ingredients for human applications.This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.